Notably, the relationship between α- and β-secretase pathway processing is significantly altered in idiopathic autism vs. controls, indicating additional APP-related pathways in “anabolic” effects associated with idiopathic autism are not explained simply by mGluR5-based disruption of APP expression. This evidence concerns the gene GRM5 and autism.